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Introduction
We have previously shown that medication overuse is
prevalent among individuals self-medicating regular
headache.
Aims
In this study we evaluated self-medicating headache
patients from a broader perspective, exploring the inter-
play between headache and concomitant pain conditions,
pain-related disability and pain medication use. Identifica-
tion of subgroups of patients could be helpful to tailor
intervention strategies.
Methods
A hierarchical cluster analysis was used to group 1021 self-
medicating headache patients according to their (1) socio-
demographics, (2) pain characteristics, (3) pain-related
disability and (4) pain medication use. Patients were
recruited in 202 Belgian community pharmacies and
fulfilled the following inclusion criteria: aged ≥18 years,
purchasing an over-the-counter systemic analgesic, experi-
encing pain ≥1 full day/month and suffering from
headache.
Results
Three subgroups were identified. Group 1 comprised
patients with low socioeconomic status, low self-rated
health, on average four concomitant pain conditions, high
pain frequency, high disability, and high rates of medica-
tion overuse. Group 2 included older patients with a mean
of two other pain syndromes, and low disability but high
pain intensity. Group 3 comprised young highly-educated
patients diagnosed with migraine, having on average one
concomitant pain condition, low pain frequency, low dis-
ability but high pain intensity, and low rates of medication
overuse.
Conclusions
We have identified three subgroups in a large sample of
individuals self-medicating headache. The marked differ-
ences across the three groups stress the importance of a
holistic assessment of headache patients and the need for
tailored strategies to reduce the risk of medication-overuse
headache in primary care.
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